Publikationen, an denen er mitarbeitet Jordi A. Matías-Guiu (3)

2024

  1. Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial

    BMJ Open, Vol. 14, Núm. 1, pp. e078661

2023

  1. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome

    eBioMedicine, Vol. 94

2019

  1. Plasma Neurofilament Light Chain in Primary Progressive Aphasia and Related Disorders: Clinical Significance and Metabolic Correlates

    Journal of Alzheimer's Disease, Vol. 72, Núm. 3, pp. 773-782